The Lancet HIV in conversation with

Episódios

• 
  Janet Turan and Zachary Kwena on home-based couples testing and counselling for HIV 26.08.2026 23min

  HIV remains underdiagnosed among men in many settings, contributing to ongoing transmission. When women seek care during pregnancy, there is an opportunity to reach out to their partners. Home-based couples testing and counselling can help to identify HIV and discuss other health issues. In this podcast, we look at a trial comparing lay counsellor delivered couples-based HIV testing with distributions of self-test kits, and standard of care in Kenya. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00104-9/fulltext
• 
  Amy Justice and Keri Althoff on the Lancet HIV Commission on ageing and HIV 27.07.2026 22min

  Living longer with HIV is one of medicine's greatest success stories, but longevity brings new challenges. By 2040, more than half of all people living with HIV are expected to be over the age of 50, and their health pathways during ageing are very heterogeneous. What does that mean for patients, clinicians, and health systems worldwide? Are our health systems ready for this shift in the HIV ageing demographics? In this episode, Amy Justice and Keri Althoff discuss The Lancet HIV Commission on Ageing and HIV: A global perspective, exploring why the future of HIV care must shift beyond viral suppression toward healthy ageing, integrated care, and what matters most to people living with HIV. Click here to read the full commission and related material:  www.thelancet.com/commissions-do/ageing-and-hiv If you want to discover more you can download the related infographic at: www.thelancet.com/infographics-do/ageing-with-HIV-26 And a video form the authors of the commission at: https://www.youtube.com/watch?v=WHhBYh1zKMI
• 
  Annemarie Wensing, Tommaso Clemente, and Arjen Stam on clinical management of persistent low-level viremia in people on antiretroviral therapy 01.07.2026 19min

  Some people on HIV treatment have a viral load that won't fully suppress. In this episode, we speak with Annemarie Wensing (University Medical Center Utrecht in The Netherlands and Witwatersrand University in South Africa), Aryen Stam (University Medical Center Utrecht) and Tomasso Clemente (IRCCS San Raffaele Scientific Institute in Milan, Itally); authors of an international consensus published in The Lancet HIV, bringing together nearly 100 experts across six continents to tackle one of the least standardized challenges in HIV care: low-level viremia. What does the evidence actually say about risk? When should a clinician act? How to communicate a low-level viremia diagnosis to a patient? And what does this guidance mean for the people being treated in settings where resistance testing and second-line options are out of reach? Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00107-4/fulltext
• 
  David Coelho and Arjee Restar on mental health disparities among transgender women and transfeminine people living with HIV 15.06.2026 29min

  Transgender women and transfeminine people living with HIV face layers of stigma and multiple challengers that contribute to high levels of mental ill health and substance use—new research quantifies this burden, and we discuss the findings with the authors and explore drivers and solutions. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00004-4/fulltext
• 
  Esteban Martinez and Steven Grinspoon on non-communicable diseases and the REPRIEVE trial 29.04.2026 25min

  Non-communicable diseases (NCDs) increasingly represent a leading cause of morbidity and mortality among people with HIV. People with HIV are at high risk of developing NCDs, often at younger ages and more severely than people without HIV. Esteban Martinez from the Hospital Clinic and University of Barcelona, and Steven Grinspoon from the Massachusetts General Hospital and Harvard Medical School, join us to explore the importance of NCDs and how data from the REPRIEVE trial can help us understand and prevent the underlying causes increasing the risk of NCDs in people with HIV. Click here to read the full articles: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00031-7/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00354-6/fulltext https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00036-6/fulltext
• 
  Colette Smith on the Positive Voices UK survey recording health needs of people living with HIV 02.04.2026 13min

  People living with HIV often have many health needs beyond their antiretroviral medication. Editor in Chief Peter Hayward talks to Colette Smith of the Institute for Global Health at University College London about results of the Positive Voices survey identifying unmet health needs for people with HIV in the UK. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00332-7/fulltext Continue this conversation on social! Follow us today at... h...
• 
  Eran Shorer on Parkinsonism in people with virally suppressed HIV 12.03.2026 19min

  Ageing with HIV brings new challenges. Even with effective ART, people ageing with HIV face increased risk of parkinsonism. Eran F Shorer from the Icahn School of Medicine at Mount Sinai joins us to explore the latest research on brain changes, motor slowing, and the need for better diagnosis and treatment. https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00262-0/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://insta...
• 
  Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa 10.12.2025 43min

  Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series. Together they discuss withstanding external funding shocks, meaningful community in...
• 
  Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV 27.11.2025 21min

  Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances. Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://...
• 
  Deborah Persaud on the possibility of HIV remission in neonates 05.11.2025 35min

  In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far. Read the full article: www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup http...
• 
  Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis 02.10.2025 17min

  Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving outcomes for people living with advanced HIV. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00163-8/fulltext?dgcid=buzzsprout_icw_podcast_October_25_lanhiv Cont...
• 
  Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV 28.08.2025 18min

  Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv Cont...
• 
  Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda 31.07.2025 25min

  Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprou...
• 
  Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV 01.07.2025 16min

  In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h...
• 
  Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV 28.05.2025 13min

  Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resolution of MASLD in people with HIV. Read the full article: https://www.thelancet.com/journals/lanh...
• 
  Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality 01.05.2025 24min

  Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic? Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout...
• 
  Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes 28.03.2025 21min

  Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression. Read the article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv And the personal view: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid...
• 
  Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women 11.03.2025 23min

  Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h...
• 
  Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure 05.02.2025 24min

  Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagr...
• 
  Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish) 05.12.2024 33min

  Please note: this podcast is entirely in Spanish Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH. Lea la Serie completa: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhi...